Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report

BACKGROUND: Chemotherapy is considered the most appropriate treatment for metastatic uterine sarcoma, despite its limited efficacy. No other treatment has been conclusively proved to be a real alternative, but some reports suggest that anti-hormonal therapy could be active in a small subset of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Romano, P., Jurado, M., Idoate, M. A., Arbea, L., Hernandez-Lizoain, J. L., Cano, D., Paramo, J. A., Martin-Algarra, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397750/
https://www.ncbi.nlm.nih.gov/pubmed/28424084
http://dx.doi.org/10.1186/s13256-017-1262-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397750/
https://www.ncbi.nlm.nih.gov/pubmed/28424084
http://dx.doi.org/10.1186/s13256-017-1262-y

Ejemplares similares